About Klaudia Pacewicz
Head of Product Leading Precision Oncology and Genomic Interpretation at Intelliseq.
Klaudia partners with engineering, science, and commercial teams at Intelliseq to ship genomic interpretation tools used by diagnostic laboratories and clinicians around the world.
Building Product at Intelliseq
Klaudia has spent her career at the intersection of genomics and product, joining Intelliseq to help turn the company’s iFlow engine into a platform that laboratories could run in production, not just a research prototype.
That grounding in both the science and the workflow still shapes how she scopes every feature: it has to hold up in a regulated, high-stakes clinical setting, not just a demo.
Leading Oncology & Variant Curation
As Intelliseq’s product surface expanded into oncology, Klaudia took ownership of GeneSpect’s somatic and variant curation tools — the modules labs use to interpret cancer genomes and match patients to therapies.
Under her product leadership, iFlow added Genomenon’s Cancer Knowledgebase for evidence-based somatic variant interpretation, deepened its NGS partnership with OGT for myeloid malignancy panels, and connected to Manifold’s governed AI research environments — extending the platform from rare disease diagnostics into precision oncology and translational research.
Today
Klaudia now leads product for Intelliseq’s full iFlow platform and its GeneSpect Reporter suite — spanning hereditary disease, somatic oncology, pharmacogenomics, and polygenic risk — built to run inside HIPAA-, GDPR-, and ISO13485-compliant labs worldwide.
Speaking & Industry Recognition
Klaudia took the stage at the Association for Molecular Pathology’s AMP 2025 Annual Meeting, presenting “Precision, Context, and Control: iFlow’s New Tools for Oncology & Variant Curation” on the Innovation Spotlight Stage.
She was also invited by Prague.bio as a featured guest speaker to the Central European biotech community, and represents Intelliseq’s product vision across its partnership announcements with OGT, Genomenon, and Manifold. See the Press & Media page for the full list.